Reproductive Endocrinology Luteal Phase

Early follicular phase follicle-stimulating hormone treatment of endometrial luteal phase deficiency

Balasch J, Jové IC, Márquez M, Vanrell JA

Published December 1990 Fertility and Sterility, 54(6), 1004-1007
DOI 10.1016/s0015-0282(16)53995-8 PMID 2123158

RRM Academy Synopsis

Early-cycle FSH corrected luteal phase deficiency in 7 of 15 women

Early-cycle FSH injections corrected the uterine lining defect in 7 of 15 women with luteal phase deficiency. This 1990 Barcelona study used biopsies to document the defect over at least two cycles. Of 5 women with a corrected defect and no other infertility factor, 2 had a baby.

Key Findings

  • Seven of 15 women (46.7%) with endometrial luteal phase deficiency showed normal endometrial dating during the first treated cycle.
  • Two of 5 women with a corrected defect and no other infertility factor conceived on FSH given for six cycles. Both carried singleton pregnancies to term.
  • Five additional women with normal luteal function had a third biopsy during FSH treatment, and the normal secretory pattern held in every case.
  • Hormone levels were similar in control and treatment cycles, and no side effects were noted.

Interpretation

This 1990 study followed 15 women with luteal phase deficiency. Each woman's treated cycle was compared to her own earlier untreated cycle, using blinded endometrial biopsies. Of 5 women with a corrected defect and no other infertility factor, 2 conceived. The authors propose two forms of luteal phase deficiency. One form ties to abnormal follicle development. The other follows normal follicle events. The authors note that a method to tell the two forms apart is still needed. The findings support larger studies of early-cycle FSH treatment for luteal phase deficiency.

RRM Context

Restorative reproductive medicine asks why a luteal phase falls short. The authors suggest some cases begin in the follicular phase, before ovulation. The lining defect often appeared alongside normal midluteal progesterone. All 15 women had normal-length luteal phases on temperature charts. The lag showed up only on biopsy.

Abstract

Fifteen infertile women with inadequate luteal phase, histologically documented in at least two separate cycles, and normal midluteal plasma levels of progesterone (greater than or equal to 10 ng/mL), estradiol (70 to 300 pg/mL), and prolactin (less than 20 ng/mL) received "pure" follicle-stimulating hormone (pFSH), 150 IU intramuscularly, for 4 days (days 1 to 4 of the cycle). The endometrial defect was corrected in 7 of the 15 (46.7%) patients during the first treated cycle. Hormonal levels were similar in control and treatment cycles. Two of 5 patients with no additional infertility factors except luteal phase deficiency (LPD) became pregnant and carried to term singleton pregnancies. In 5 additional infertile patients with normal luteal function as assessed by endometrial histological study (2 cycles) and hormone measurements (first study cycle), a third biopsy was performed in a consecutive cycle under pFSH administration. In no case was the normal secretory pattern impaired. It is concluded that (1) some forms of LPD may be successfully treated by early follicular pFSH therapy and (2) pFSH does not alter the normal endometrial secretory pattern.

Topics

By this author

Related research

Reproductive Endocrinology › Luteal Phase › Luteal Phase Deficiency · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances · Therapeutics › Hormonal Agents › Gonadotropins
Juan Balasch, Inmaculada C. Jové, Manuel Márquez, Juan A. Vanrell
J Balasch, I Jové, M Márquez, J Vanrell
PMID 2123158 2123158 DOI 10.1016/s0015-0282(16)53995-8 10.1016/s0015-0282(16)53995-8 Balasch et al. 1990, Balasch 1990